FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3023723352> ?p ?o ?g. }

• W3023723352 endingPage "23688" @default.
• W3023723352 startingPage "23677" @default.
• W3023723352 abstract "As a newly emerging treatment strategy for many diseases, hydrogen therapy has attracted a lot of attention because of its excellent biosafety. However, the high diffusivity and low solubility of hydrogen make it difficult to accumulate in local lesions. Herein, we develop a H2 self-generation nanoplatform by in situ water splitting driven by near-infrared (NIR) laser. In this work, core–shell nanoparticles (CSNPs) of NaGdF4:Yb,Tm/g-C3N4/Cu3P (UCC) nanocomposites as core encapsulated with zeolitic imidazolate framework-8 (ZIF-8) modified with folic acid as shell are designed and synthesized. Due to the acid-responsive ZIF-8 shell, enhanced permeability and retention (EPR) effect, and folate receptor-mediated endocytosis, CSNPs are selectively captured by tumor cells. Upon 980 nm laser irradiation, CSNPs exhibit a high production capacity of H2 and active oxygen species (ROS), as well as an appropriate photothermal conversion temperature. Furthermore, rising temperature increases the Fenton reaction rate of Cu(I) with H2O2 and strengthens the curative effect of chemodynamic therapy (CDT). The excess glutathione (GSH) in tumor microenvironment (TME) can deplete positive holes produced in the valence band of g-C3N4 in the g-C3N4/Cu3P Z-scheme heterojunction. GSH also can reduce Cu(II) to Cu(I), ensuring a continuous Fenton reaction. Thus, a NIR-driven H2 production nanoplatform is constructed for H2-mediated cascade-amplifying multimodal synergetic therapy." @default.
• W3023723352 created "2020-05-13" @default.
• W3023723352 creator A5015195367 @default.
• W3023723352 creator A5022358737 @default.
• W3023723352 creator A5023492006 @default.
• W3023723352 creator A5060114167 @default.
• W3023723352 date "2020-05-08" @default.
• W3023723352 modified "2023-10-11" @default.
• W3023723352 title "NIR-Driven Water Splitting H₂ Production Nanoplatform for H₂-Mediated Cascade-Amplifying Synergetic Cancer Therapy" @default.
• W3023723352 cites W2010278502 @default.
• W3023723352 cites W2169657429 @default.
• W3023723352 cites W2313709827 @default.
• W3023723352 cites W2618635225 @default.
• W3023723352 cites W2743475749 @default.
• W3023723352 cites W2766957696 @default.
• W3023723352 cites W2773340742 @default.
• W3023723352 cites W2791472396 @default.
• W3023723352 cites W2792944830 @default.
• W3023723352 cites W2891672228 @default.
• W3023723352 cites W2893441209 @default.
• W3023723352 cites W2896227976 @default.
• W3023723352 cites W2907351128 @default.
• W3023723352 cites W2924100078 @default.
• W3023723352 cites W2935890344 @default.
• W3023723352 cites W2944388586 @default.
• W3023723352 cites W2958981258 @default.
• W3023723352 cites W2962099392 @default.
• W3023723352 cites W2962938520 @default.
• W3023723352 cites W2965253935 @default.
• W3023723352 cites W2966111662 @default.
• W3023723352 cites W2977879878 @default.
• W3023723352 cites W2980353764 @default.
• W3023723352 cites W2980577800 @default.
• W3023723352 cites W2981377486 @default.
• W3023723352 cites W2985562150 @default.
• W3023723352 cites W2988950616 @default.
• W3023723352 cites W2992410143 @default.
• W3023723352 cites W2992583623 @default.
• W3023723352 cites W2994875356 @default.
• W3023723352 cites W3001233970 @default.
• W3023723352 cites W3008648944 @default.
• W3023723352 doi "https://doi.org/10.1021/acsami.0c03852" @default.
• W3023723352 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32380825" @default.
• W3023723352 hasPublicationYear "2020" @default.
• W3023723352 type Work @default.
• W3023723352 sameAs 3023723352 @default.
• W3023723352 citedByCount "37" @default.
• W3023723352 countsByYear W30237233522020 @default.
• W3023723352 countsByYear W30237233522021 @default.
• W3023723352 countsByYear W30237233522022 @default.
• W3023723352 countsByYear W30237233522023 @default.
• W3023723352 crossrefType "journal-article" @default.
• W3023723352 hasAuthorship W3023723352A5015195367 @default.
• W3023723352 hasAuthorship W3023723352A5022358737 @default.
• W3023723352 hasAuthorship W3023723352A5023492006 @default.
• W3023723352 hasAuthorship W3023723352A5060114167 @default.
• W3023723352 hasConcept C127413603 @default.
• W3023723352 hasConcept C171250308 @default.
• W3023723352 hasConcept C178790620 @default.
• W3023723352 hasConcept C181199279 @default.
• W3023723352 hasConcept C182606246 @default.
• W3023723352 hasConcept C185592680 @default.
• W3023723352 hasConcept C192562407 @default.
• W3023723352 hasConcept C202189072 @default.
• W3023723352 hasConcept C2780596747 @default.
• W3023723352 hasConcept C2992152733 @default.
• W3023723352 hasConcept C42360764 @default.
• W3023723352 hasConcept C48349386 @default.
• W3023723352 hasConcept C49040817 @default.
• W3023723352 hasConcept C512968161 @default.
• W3023723352 hasConcept C538909803 @default.
• W3023723352 hasConcept C55493867 @default.
• W3023723352 hasConcept C60644358 @default.
• W3023723352 hasConcept C79794668 @default.
• W3023723352 hasConcept C86803240 @default.
• W3023723352 hasConcept C92880739 @default.
• W3023723352 hasConceptScore W3023723352C127413603 @default.
• W3023723352 hasConceptScore W3023723352C171250308 @default.
• W3023723352 hasConceptScore W3023723352C178790620 @default.
• W3023723352 hasConceptScore W3023723352C181199279 @default.
• W3023723352 hasConceptScore W3023723352C182606246 @default.
• W3023723352 hasConceptScore W3023723352C185592680 @default.
• W3023723352 hasConceptScore W3023723352C192562407 @default.
• W3023723352 hasConceptScore W3023723352C202189072 @default.
• W3023723352 hasConceptScore W3023723352C2780596747 @default.
• W3023723352 hasConceptScore W3023723352C2992152733 @default.
• W3023723352 hasConceptScore W3023723352C42360764 @default.
• W3023723352 hasConceptScore W3023723352C48349386 @default.
• W3023723352 hasConceptScore W3023723352C49040817 @default.
• W3023723352 hasConceptScore W3023723352C512968161 @default.
• W3023723352 hasConceptScore W3023723352C538909803 @default.
• W3023723352 hasConceptScore W3023723352C55493867 @default.
• W3023723352 hasConceptScore W3023723352C60644358 @default.
• W3023723352 hasConceptScore W3023723352C79794668 @default.
• W3023723352 hasConceptScore W3023723352C86803240 @default.
• W3023723352 hasConceptScore W3023723352C92880739 @default.
• W3023723352 hasFunder F4320321001 @default.
• W3023723352 hasIssue "21" @default.

• next